Figure 9From: The Treatment of Vasomotor Rhinitis With Intranasal CorticosteroidsPlacebo-controlled comparison of FP nasal spray given as a AM/PM divided dose of 200 and 400 μ g. Patient-rated mean total nasal symptom scores (TNSS) in total, non-NARES, and NARES populations [60].Back to article page